Navigation Links
Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research

BOISE, Idaho, March 17 /PRNewswire/ -- A new professional services company has been launched focused on accelerating the connections of university-based bioscience research with commercial development opportunities. Bioscience Bridge, LLC was formed by Michelle Travis, principal and managing director, along with Mark Stinson, chief strategic officer.


Bioscience Bridge is also supported by a team of consultants with experience in product strategy, marketing, business development, life science, legal, licensing and commercialization.

According to Ms. Travis, "We know that some of the best bioscience research comes from universities. Bioscience Bridge helps tech transfer offices at these universities get the technology out into the marketplace. This may be in the form of a start-up company or licensing agreements."

She adds, "We have the industry experience to bring the right companies to the universities."

University offices of technology transfer (OTT) have contacted Bioscience Bridge when they have a technology that is "stuck" or are looking for a technology portfolio evaluation.

Bioscience Bridge has several proprietary processes to assist OTTs:

  • Evaluation – using B.E.A.M.S.® to analyze university's specific technology or entire portfolio
  • Strategy – facilitating a Strategic GPS® to guide early stage technologies
  • Promotion – getting the right message in the right medium to the right people
  • Negotiation – assisting with the contract terms process leading to commercial agreements

Bioscience Bridge works with universities and life science companies around the world. They will be attending the AUTM 2010 Annual Meeting in New Orleans March 18-21, BIO International 2010 in Chicago May 3-6, and the Licensing Executives Society Spring Meeting in Boston, May 19-21. More information about Bioscience Bridge services, capabilities, and connections is online at

About Bioscience Bridge, LLC:

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we support tech transfer offices with our bioscience industry experience and a proven process in the evaluation, strategy, promotion and negotiation of licensing, collaboration or start up arrangements. The agency is a member of Association of Technology Managers (AUTM) and the Licensing Executives Society (LES). More information is on the Bioscience Bridge website at

SOURCE Bioscience Bridge, LLC

Back to top



SOURCE Bioscience Bridge, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
2. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
3. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
4. YM BioSciences closes US$17.5 million financing
5. YM BioSciences to raise approximately US$15 million
6. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
7. TEI Biosciences PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association
8. KGI Study Reveals Diverse and Vibrant Regional Bioscience Industry
9. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
10. YM BioSciences granted two US patents for AeroLEF(R)
11. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):